Key research & article

Last updated: 2025 Apr 18

Total hit(s): 15916

S.No.
1	40381203	Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac(R)) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study.	Hum Vaccin Immunother	2025 Dec	4.7	1
2	40135763	Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies.	Ann Med	2025 Dec	3.01	1
3	40134119	Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic.	Hum Vaccin Immunother	2025 Dec	4.7	1
4	40156199	COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community setting.	Hum Vaccin Immunother	2025 Dec	4.7	1
5	40152750	Long-term alveolar-capillary diffusion impairments after severe SARS-CoV-2 pneumonia.	Ann Med	2025 Dec	3.01	1
6	40195167	Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study.	Expert Rev Vaccines	2025 Dec	4.37	1
7	40382672	The double burden of stressful life events among professional nurses: public mass shootings during the COVID-19 pandemic.	Int J Qual Stud Health Well-being	2025 Dec		1
8	40376714	Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial.	Hum Vaccin Immunother	2025 Dec	4.7	1
9	40366666	A four-week study on the toxicity of repeated intramuscular administration of plant-based BA-CoV2-0301 vaccine against SARS-CoV-2 in Sprague-Dawley rats.	J Immunotoxicol	2025 Dec		1
10	40338231	Assessing vaccine coverage and delivery strategies for influenza and COVID-19 among Italian healthcare workers: A 2015-2023 case study.	Hum Vaccin Immunother	2025 Dec	4.7	1
11	40371698	Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity.	J Enzyme Inhib Med Chem	2025 Dec	8.6	1
12	40214651	From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine.	Hum Vaccin Immunother	2025 Dec	4.7	1
13	40358138	Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals.	Hum Vaccin Immunother	2025 Dec	4.7	1
14	40497727	The effect of SARS-CoV-2 and influenza vaccination on endemic coronavirus-related mortality: A retrospective cohort study in Brazil.	Hum Vaccin Immunother	2025 Dec	4.7	1
15	40032512	Involvement of oxidative stress in post-acute sequelae of COVID-19: clinical implications.	Redox Rep	2025 Dec		1
16	40382340	Increased dialysis symptom index burden in maintenance hemodialysis patients during the COVID-19 lockdown period.	Ann Med	2025 Dec	3.01	1
17	40411306	Antibody-dependent enhancement of SARS-CoV-2, the impact of variants and vaccination.	Hum Vaccin Immunother	2025 Dec	4.7	1
18	40407705	T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine.	Hum Vaccin Immunother	2025 Dec	4.7	1
19	40179339	Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022-2023.	Hum Vaccin Immunother	2025 Dec	4.7	1
20	40028815	Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.	Hum Vaccin Immunother	2025 Dec	4.7	1
21	39773304	Considering the impact of vaccine communication in the COVID-19 pandemic among adults in Canada: A qualitative study of lessons learned for future vaccine campaigns.	Hum Vaccin Immunother	2025 Dec	4.7	1
22	40051347	Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection.	Hum Vaccin Immunother	2025 Dec	4.7	1
23	39763233	Changes in seasonal influenza vaccination uptake among older adults during and after the COVID-19 pandemic: Repeated random telephone surveys.	Hum Vaccin Immunother	2025 Dec	4.7	1
24	39729392	COVID-19 vaccine acceptance and preference for future delivery among language minority, newcomer, and racialized peoples in Canada: a national cross-sectional and longitudinal study.	Ann Med	2025 Dec	3.01	1
25	39720838	Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged >/=18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.	Expert Rev Vaccines	2025 Dec	4.37	1